Patents Assigned to BRIGHTGENE BIO-MEDICAL TECHNOLOGY (SUZHOU) CO., LTD
  • Patent number: 10072122
    Abstract: Apparatus relates to a carbonate polymer containing a functional group of disulfide five-membered ring in the side chain and application thereof. The polymer can be prepared from cyclic carbonate monomer containing a disulfide five-membered ring functional group through the activity controllable ring-opening polymerization. For polymer, molecular weight is controlled, molecular weight distribution is narrowed and does not require the protection and deprotection procedures. Polymer prepared from the carbonate monomer through the ring-opening polymerization has biodegradability, can be used for controlling drugs release system, and can be used to prepare tumor-targeted nano-drug carrier which is sensitive to reduction and is reversible cross-linking, can support long circulation in the body, in high concentration of cancers cells can rapidly release cross-linking in the cancer cells, to release drugs, to kill cancer cells with high efficiency and specificity.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: September 11, 2018
    Assignee: BRIGHTGENE BIO-MEDICAL TECHNOLOGY (SUZHOU) CO., LTD.
    Inventors: Fenghua Meng, Yan Zou, Zhiyuan Zhong, Jiandong Yuan
  • Publication number: 20150322071
    Abstract: A method is disclosed for preparing Ticagrelor using the compounds as represented by intermediates of formula (2), formula (1-b), formula (1-c), formula (1-d) and formula (1-e), wherein the definition of R is as described in the description, and also disclosed is a method for preparing the intermediate of formula (2) and the use thereof in the preparation of Ticagrelor.
    Type: Application
    Filed: December 4, 2013
    Publication date: November 12, 2015
    Applicant: BRIGHTGENE BIO-MEDICAL TECHNOLOGY (SUZHOU) CO., LTD
    Inventors: Jiandong YUAN, Qiao JIANG, Xiang LI